Epidarex invests in early-stage,
high growth life science and health technology companies
in emerging and under-ventured research hubs within the UK and US

Epidarex Provides Equity Capital to Start-Ups, Including University Spin-outs

Through our deep scientific and industry network we are able to identify transformative life science investments in under-ventured regions of the US and UK, building companies from scratch to create value and shared success.

Our international management team has a track record of successfully partnering with scientists and entrepreneurs to develop highly innovative products for the global healthcare market. We leverage our extensive relationships, industry operating experience and a disciplined investment approach to add significant value to our portfolio companies and to generate strong returns on investment for our investors.

We believe in working closely with the management of our portfolio companies to drive the translation of their research into world-class businesses.

Our global network includes investment professionals, scientists, industry executives, health practitioners, policy experts, regulatory advisors and business development leaders. This strong network contributes significantly to the growth and development of our portfolio companies.

 

The Epidarix Team

Experienced Professionals

A. Sinclair Dunlop

Managing Partner

Kyparissia Sirinakis

Managing Partner

Elizabeth Roper Ph.D.

Partner

Peter Finan Ph.D.

Partner

Terri Burke

Venture Partner

Henning Steinhagen Ph.D.

Venture Partner

Anthony Voveris

Director of Finance

Mary Canning Ph.D.

Principal

Matthew Miessau

Associate

Alex Hammond

Analyst

Rachel Haynes

Operations Manager

Amanda Crook

Operations Manager